| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 45,31% | 9,27% | -31,48% | · |
| SPDR MSCI EUROPE VALUE UCITS ETF | RVI EUROPA VALOR | 45,31% | 67,40% | 91,04% | 179,01% |
| BGF EMERGING MARKETS I2 USD | RVI EMERGENTES | 45,30% | 36,68% | · | · |
| OCCIDENT BOLSA ESPAÑOLA, FI | RV ESPAÑA | 45,30% | 98,83% | 126,34% | 143,83% |
| ABRDN SICAV I-JAPANESE SUSTAINABLE EQUITY FUND L ACC EUR | RVI JAPÓN | 45,29% | 62,63% | · | · |
| BGF US FLEXIBLE EQUITY A2 EUR (HEDGED) | RVI USA | 45,29% | 64,21% | 54,90% | 194,30% |
| TEMPLETON JAPAN W (ACC) EUR | RVI JAPÓN | 45,29% | 80,19% | 76,88% | 146,25% |
| AMUNDI FUNDS EMERGING MARKETS EQUITY FOCUS A EUR HGD (C) | RVI EMERGENTES | 45,28% | 41,35% | 0,83% | 61,86% |
| BNP PARIBAS ASIA EX-JAPAN EQUITY PRIVILEGE CAP | RVI ASIA EX-JAPÓN | 45,28% | 47,60% | 12,69% | 107,73% |
| AB SICAV I-GLOBAL VALUE PORTFOLIO I USD | RVI GLOBAL VALOR | 45,27% | 61,04% | 64,24% | 146,14% |
| BGF EMERGING MARKETS I2 EUR | RVI EMERGENTES | 45,27% | 36,58% | 2,24% | · |
| GOLDMAN SACHS EMERGING MARKETS EQUITY ESG PORTFOLIO I EUR CAP | RVI EMERGENTES | 45,27% | 54,95% | 15,64% | · |
| BARINGS EASTERN EUROPE FUND I USD INC | RVI EMERGENTES EUROPA | 45,26% | · | · | · |
| SCHRODER ISF EMERGING MARKETS EQUITY ALPHA C ACC USD | RVI EMERGENTES | 45,26% | 56,57% | 29,31% | · |
| JANUS HENDERSON FUND EMERGING MARKETS H2 USD | RVI EMERGENTES | 45,22% | 44,93% | 14,82% | · |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 45,21% | 9,10% | -31,62% | · |
| BARINGS EASTERN EUROPE FUND I GBP INC | RVI EMERGENTES EUROPA | 45,20% | · | · | · |
| SCHRODER ISF LATIN AMERICAN A DIS USD | RVI LATINOAMÉRICA | 45,20% | 28,66% | 25,45% | 52,66% |
| ALKEN FUND - CONTINENTAL EUROPE SEU1 | RVI EUROPA | 45,19% | 88,43% | 134,62% | · |
| CT (LUX) RESPONSIBLE GLOBAL EMERGING MARKETS EQUITY R USD ACC | RVI EMERGENTES | 45,19% | 41,88% | 18,49% | · |
